Alessio Branchini

1.0k total citations
45 papers, 700 citations indexed

About

Alessio Branchini is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Alessio Branchini has authored 45 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 19 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Alessio Branchini's work include Hemophilia Treatment and Research (24 papers), Blood Coagulation and Thrombosis Mechanisms (19 papers) and Platelet Disorders and Treatments (15 papers). Alessio Branchini is often cited by papers focused on Hemophilia Treatment and Research (24 papers), Blood Coagulation and Thrombosis Mechanisms (19 papers) and Platelet Disorders and Treatments (15 papers). Alessio Branchini collaborates with scholars based in Italy, United States and Belgium. Alessio Branchini's co-authors include Mirko Pinotti, Francesco Bernardi, Dario Balestra, Elisabetta Caselli, Paola Antonioli, Pier Giorgio Balboni, Sante Mazzacane, Marcello Baroni, Paolo Pinton and Daniela Platano and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Blood.

In The Last Decade

Alessio Branchini

41 papers receiving 694 citations

Peers

Countries citing papers authored by Alessio Branchini

Since Specialization

Citations

This map shows the geographic impact of Alessio Branchini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessio Branchini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessio Branchini more than expected).

Fields of papers citing papers by Alessio Branchini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessio Branchini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessio Branchini. The network helps show where Alessio Branchini may publish in the future.

Co-authorship network of co-authors of Alessio Branchini

This figure shows the co-authorship network connecting the top 25 collaborators of Alessio Branchini. A scholar is included among the top collaborators of Alessio Branchini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessio Branchini. Alessio Branchini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineered tRNAs efficiently suppress CDKL5 premature termination codons 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Alessio Branchini, Mirko Pinotti, Angelisa Frasca, Joseph J. Porter, John D. Lueck, Nicoletta Landsberger	4
2	1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects 2023 ·International Journal of Molecular Sciences ·Gaia Pedriali, Daniela Ramaccini, Esmaa Bouhamida, Alessio Branchini, (unknown), Elisabetta Tonet, (unknown), Simone Patergnani, Mirko Pinotti, Claudio Trapella, Carlotta Giorgi, Elena Tremoli, Gianluca Campo, Giampaolo Morciano, Paolo Pinton	6
3	The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms 2022 ·Journal of Thrombosis and Haemostasis ·(unknown), Stefano Lancellotti, Alessio Branchini, (unknown), Maria Francesca Testa, Barbara Lunghi, Francesco Bernardi, Mirko Pinotti, Betti Giusti, Giancarlo Castaman, Raimondo De Cristofaro	4
4	Translational readthrough at <i>F8</i> nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association 2022 ·Haematologica ·Maria Francesca Testa, (unknown), Francesco Bernardi, (unknown), Donata Belvini, Paolo Radossi, Giancarlo Castaman, Mirko Pinotti, Alessio Branchini	4
5	A recoded view on the F9 p.Cys178Ter pathogenic mechanism 2020 ·Thrombosis Research ·Alessio Branchini, Mirko Pinotti	1
6	Design of a novel factor IX albumin fusion protein with enhanced coagulant activity and pharmacokinetic profile 2020 ·Institutional Research Information System University of Ferrara (University of Ferrara) ·(unknown), Jeannette Nilsen, (unknown), (unknown), Mirko Pinotti, (unknown), Derry C. Roopenian, Inger Sandlie, Jan Terje Andersen, Alessio Branchini	1
7	Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 2020 ·Thrombosis Research ·Nicole Ziliotto, (unknown), Erica Menegatti, Marcello Baroni, Barbara Lunghi, Fabrizio Salvi, Manuela Ferracin, Alessio Branchini, Donato Gemmati, F Mascoli, Paolo Zamboni, Francesco Bernardi, Giovanna Marchetti	3
8	Functional polymorphisms in the LDLR and pharmacokinetics of Factor VIII concentrates 2019 ·Journal of Thrombosis and Haemostasis ·Barbara Lunghi, Francesco Bernardi, Nicola Martinelli, Sabrina Frusconi, Alessio Branchini, Silvia Linari, Giovanna Marchetti, Giancarlo Castaman, Massimo Morfini	16
9	An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 2019 ·Frontiers in Genetics ·Dario Balestra, Iva Maestri, Alessio Branchini, (unknown), Francesco Bernardi, Mirko Pinotti	10
10	Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 2019 ·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·(unknown), (unknown), Elena Barbon, Antonia Follenzi, Matteo Bovolenta, Francesco Bernardi, Alessio Branchini, Mirko Pinotti	9
11	The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies 2018 ·Thrombosis Research ·(unknown), (unknown), (unknown), Dario Balestra, Francesco Bernardi, Mirko Pinotti, Alessio Branchini	7
12	Impact of a Probiotic-Based Cleaning Intervention on the Microbiota Ecosystem of the Hospital Surfaces: Focus on the Resistome Remodulation 2016 ·PLoS ONE ·Elisabetta Caselli, Maria D’Accolti, (unknown), (unknown), (unknown), (unknown), Alessio Branchini, Paola Antonioli, Pier Giorgio Balboni, Dario Di Luca, Sante Mazzacane	74
13	Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 2016 ·Journal of Thrombosis and Haemostasis ·Alessio Branchini, (unknown), (unknown), (unknown), Francesca Bernardi, Mirko Pinotti	19
14	Activated factor VII–antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 2016 ·Journal of Thrombosis and Haemostasis ·Nicola Martinelli, Domenico Girelli, Marcello Baroni, Patrizia Guarini, Marco Sandri, Barbara Lunghi, Federica Tosi, Alessio Branchini, (unknown), Barry Woodhams, Francesco Bernardi, Oliviero Olivieri	23
15	The carboxyl‐terminal region is NOT essential for secreted and functional levels of coagulation factor X 2015 ·Journal of Thrombosis and Haemostasis ·Alessio Branchini, Marcello Baroni, (unknown), Francesco Puzzo, (unknown), (unknown), Donato Gemmati, Francesco Bernardi, Mirko Pinotti	17
16	Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 2015 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Marcello Baroni, Giulia Pavani, Mirko Pinotti, Alessio Branchini, Francesco Bernardi, Rodney M. Camire	8
17	Replacement of the Y450 (c234) phenyl ring in the carboxyl‐terminal region of coagulation factor IX causes pleiotropic effects on secretion and enzyme activity 2013 ·FEBS Letters ·Alessio Branchini, (unknown), Maria Gabriella Mazzucconi, Francesca Biondo, (unknown), Maria Patrizia Bicocchi, Francesco Bernardi, Mirko Pinotti	17
18	Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant 2012 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Nicola Cavallari, Dario Balestra, Alessio Branchini, Iva Maestri, (unknown), Werasak Sasanakul, Guglielmo Mariani, (unknown), Francesco Bernardi, Mirko Pinotti	19
19	Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 2011 ·Haematologica ·Alessio Branchini, Lara Rizzotto, Giuliano Mariani, Mariasanta Napolitano, Mario Lapecorella, Muriel Giansily‐Blaizot, (unknown), Alessandro Canella, Mirko Pinotti, (unknown)	20
20	Chronic sleep deprivation markedly reduces coagulation factor VII expression 2010 ·Haematologica ·Mirko Pinotti, Cristiano Bertolucci, Elena Frigato, Alessio Branchini, Nicola Cavallari, Kenkichi Baba, Susana Contreras‐Alcantara, J. Christopher Ehlen, Francesco Bernardi, Ketema N. Paul, Gianluca Tosini	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact